γ-Secretase processing and effects of γ-Secretase inhibitors and modulators on long Aβ Peptides in cells

Journal of Biological Chemistry

Volumn 289, Issue 6, 2014, Pages 3276-3287

  Ran, Yong ^a   Cruz, Pedro E ^a   Ladd, Thomas B ^a   Fauq, Abdul H ^b   Jung, Joo In ^a   Matthews, Julian ^a   Felsenstein, Kevin M ^a   Golde, Todd E ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; AMYLOID; AMYLOID PRECURSOR PROTEIN; INTRAMEMBRANE PROTEOLYSIS; PROTEASE;

AMYLOID BETA-PEPTIDES; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; HUMANS; MODELS, CHEMICAL; PRESENILIN-1; PROTEASE INHIBITORS; PROTEOLYSIS; SOLUBILITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84893701078     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.512921     Document Type: Article

References (61)

1. Hardy, J., and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease. Progress and problems on the road to therapeutics. Science 297, 353-356
2. Golde, T. E., Schneider, L. S., and Koo, E. H. (2011) Anti-A-therapeutics in Alzheimer's disease. The need for a paradigm shift. Neuron 69, 203-213
3. Jack, C. R., Jr., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., and Trojanowski, J. Q. (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9, 119-128
4. Holtzman, D. M., Morris, J. C., and Goate, A. M. (2011) Alzheimer's disease. The challenge of the second century. Sci. Transl. Med. 3, 77sr71
5. Zou, K., Liu, J., Watanabe, A., Hiraga, S., Liu, S., Tanabe, C., Maeda, T., Terayama, Y., Takahashi, S., Michikawa, M., and Komano, H. (2013)A-43 is the earliest-depositing A-species in APP transgenic mouse brain and is converted to A-41 by two active domains of ACE. Am. J. Pathol. 182, 2322-2331
6. Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C. M., Kim, G., Seekins, S., Yager, D., Slunt, H. H., Wang, R., Seeger, M., Levey, A. I., Gandy, S. E., Copeland, N. G., Jenkins, N. A., Price, D. L., Younkin, S. G., and Sisodia, S. S. (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate A-1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005-1013
7. Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lahad, E., Viitanen, M., Peskind, E., Poorkaj, P., Schellenberg, G., Tanzi, R., Wasco, W., Lannfelt, L., Selkoe, D., and Younkin, S. (1996) Secreted amyloid-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease [see comments]. Nat. Med. 2, 864-870
8. Suzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Jr., Eckman, C., Golde, T. E., and Younkin, S. G. (1994) An increased percentage of long amyloid-protein is secreted by familial amyloid-protein precursor (-APP717) mutants. Science 264, 1336-1340
9. Jarrett, J. T., Berger, E. P., and Lansbury, P. T., Jr. (1993) The carboxy terminus of-Amyloid protein is critical for the seeding of amyloid formation. Implications for pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697
10. Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., and Ihara, Y. (1994) Visualization of A-42(43) and A-40 in senile plaques with andspecific A-monoclonals. Evidence that an initially deposited species is A-42(43). Neuron 13, 45-53
11. De Strooper, B., Vassar, R., and Golde, T. (2010) The secretases. Enzymes with therapeutic potential in Alzheimer disease. Nat. Rev. Neurol. 6, 99-107
12. Weidemann, A., Paliga, K., Dürrwang, U.,Reinhard, F. B., Schuckert, O., Evin, G., and Masters, C. L. (1999) Proteolytic processing of the Alzheimer's disease amyloid precursor protein within its cytoplasmic domain by caspase-like proteases. J. Biol. Chem. 274, 5823-5829
13. Lammich, S., Kojro, E., Postina, R., Gilbert, S., Pfeiffer, R., Jasionowski, M., Haass, C., and Fahrenholz, F. (1999) Constitutive and regulated-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. U.S.A. 96, 3922-3927
14. Postina, R., Schroeder, A., Dewachter, I., Bohl, J., Schmitt, U., Kojro, E., Prinzen, C., Endres, K., Hiemke, C., Blessing, M., Flamez, P., Dequenne, A., Godaux, E., van Leuven, F., and Fahrenholz, F. (2004) A disintegrin- metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J. Clin. Invest. 113, 1456-1464
15. Asai, M., Hattori, C., Szabó, B., Sasagawa, N., Maruyama, K., Tanuma, S., and Ishiura, S. (2003) Putative function of ADAM9, ADAM10, and ADAM17 as APP-secretase. Biochem. Biophys. Res. Commun. 301, 231-235
16. Farzan, M., Schnitzler, C. E., Vasilieva, N., Leung, D., and Choe, H. (2000) BACE2, a-secretase homolog, cleaves at the-site and within the amyloid-region of the amyloid-precursor protein. Proc. Natl. Acad. Sci. U.S.A. 97, 9712-9717
17. Hussain, I., Powell, D., Howlett, D. R., Tew, D. G., Meek, T. D., Chapman, C., Gloger, I. S., Murphy, K. E., Southan, C. D., Ryan, D. M., Smith, T. S., Simmons, D. L., Walsh, F. S., Dingwall, C., and Christie, G. (1999) Identification of a Novel Aspartic Protease (Asp 2) as-Secretase. Mol. Cell Neurosci. 14, 419-427
18. Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M. A., Biere, A. L., Curran, E., Burgess, T., Louis, J. C., Collins, F., Treanor, J., Rogers, G., and Citron, M. (1999)-Secretase celavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735-741
19. Cai, H., Wang, Y., McCarthy, D., Wen, H., Borchelt, D. R., Price, D. L., and Wong, P. C. (2001) BACE1 is the major-secretase for generation of A-peptides by neurons. Nat. Neurosci. 4, 233-234
20. Wolfe, M. S., and Kopan, R. (2004) Intramembrane proteolysis. Theme and variations. Science 305, 1119-1123
21. De Strooper, B. (2003) Aph-1, Pen-2, and nicastrin with presenilin generate an active-secretase complex. Neuron 38, 9-12
22. Gu, Y., Misonou, H., Sato, T., Dohmae, N., Takio, K., and Ihara, Y. (2001) Distinct intramembrane cleavage of the-Amyloid precursor protein family resembling-secretase-like cleavage of Notch. J. Biol. Chem. 276, 35235-35238
23. Sastre, M., Steiner, H., Fuchs, K., Capell, A., Multhaup, G., Condron, M. M., Teplow, D. B., and Haass, C. (2001) Presenilin-dependent-secretase processing of-Amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Reports 2, 835-841
24. Takami, M., Nagashima, Y., Sano, Y., Ishihara, S., Morishima-Kawashima, M., Funamoto, S., and Ihara, Y. (2009)-Secretase. Successive tripeptide and tetrapeptide release from the transmembrane domain of-carboxyl terminal fragment. J. Neurosci. 29, 13042-13052
25. Wang, R., Sweeney, D., Gandy, S. E., and Sisodia, S. S. (1996) The profile of soluble amyloid-protein in cultured cell media. Detection and quantification of amyloid-protein and variants by immunoprecipitation-mass spectrometry. J. Biol. Chem. 271, 31894-31902
26. Zhao, G., Mao, G., Tan, J., Dong, Y., Cui, M. Z., Kim, S. H., and Xu, X. (2004) Identification of a new presenilin-dependent zeta-cleavage site within the transmembrane domain of amyloid precursor protein. J. Biol. Chem. 279, 50647-50650
27. Qi-Takahara, Y., Morishima-Kawashima, M., Tanimura, Y., Dolios, G., Hirotani, N., Horikoshi, Y., Kametani, F., Maeda, M., Saido, T. C., Wang, R., and Ihara, Y. (2005) Longer forms of amyloid-protein. Implications for the mechanism of intramembrane cleavage by-secretase. J. Neurosci. 25, 436-445
28. Yagishita, S., Morishima-Kawashima, M., Tanimura, Y., Ishiura, S., and Ihara, Y. (2006) DAPT-induced intracellular accumulations of longer amyloid-proteins. Further implications for the mechanism of intramembrane cleavage by-secretase. Biochemistry 45, 3952-3960
29. Esh, C., Patton, L., Kalback, W., Kokjohn, T. A., Lopez, J., Brune, D., New-ell, A. J., Beach, T., Schenk, D., Games, D., Paul, S., Bales, K., Ghetti, B., Castaño, E. M., and Roher, A. E. (2005) Altered APP processing in PDAPP (Val7173Phe) transgenic mice yields extended-length A-peptides. Biochemistry 44, 13807-13819
30. Fukumori, A., Okochi, M., Tagami, S., Jiang, J., Itoh, N., Nakayama, T., Yanagida, K., Ishizuka-Katsura, Y., Morihara, T., Kamino, K., Tanaka, T., Kudo, T., Tanii, H., Ikuta, A., Haass, C., and Takeda, M. (2006) Presenilindependent- secretase on plasma membrane and endosomes is functionally distinct. Biochemistry 45, 4907-4914
31. Maddalena, A. S., Papassotiropoulos, A., Gonzalez-Agosti, C., Signorell, A., Hegi, T., Pasch, T., Nitsch, R. M., and Hock, C. (2004) Cerebrospinal fluid profile of amyloid-peptides in patients with Alzheimer's disease determined by protein biochip technology. Neurodegener. Dis. 1, 231-235
32. Portelius, E., Dean, R. A., Gustavsson, M. K., Andreasson, U., Zetterberg, H., Siemers, E., and Blennow, K. (2010)AnovelA-isoform pattern in CSF reflects-secretase inhibition in Alzheimer disease. Alzheimers Res. Ther. 2, 7
33. Portelius, E., Van Broeck, B., Andreasson, U., Gustavsson, M. K., Mercken, M., Zetterberg, H., Borghys, H., and Blennow, K. (2010) Acute effect on the A-isoform pattern in CSF in response to-secretase modulator and inhibitor treatment in dogs. J. Alzheimers Dis. 21, 1005-1012
34. Funamoto, S., Morishima-Kawashima, M., Tanimura, Y., Hirotani, N., Saido, T. C., and Ihara, Y. (2004) Truncated carboxyl-terminal fragments of-Amyloid precursor protein are processed to amyloid-proteins 40 and 42. Biochemistry 43, 13532-13540
35. Quintero-Monzon, O., Martin, M. M., Fernandez, M. A., Cappello, C. A., Krzysiak, A. J., Osenkowski, P., and Wolfe, M. S. (2011) Dissociation between the processivity and total activity of-secretase. Implications for the mechanism of Alzheimer's disease-causing presenilin mutations. Biochemistry 50, 9023-9035
36. Chávez-Gutiérrez, L., Bammens, L., Benilova, I., Vandersteen, A., Benurwar, M., Borgers, M., Lismont, S., Zhou, L., Van Cleynenbreugel, S., Esselmann, H., Wiltfang, J., Serneels, L., Karran, E., Gijsen, H., Schymkowitz, J., Rousseau, F., Broersen, K., and De Strooper, B. (2012) The mechanism of-secretase dysfunction in familial Alzheimer disease. EMBO J. 31, 2261-2274
37. Okochi, M., Tagami, S., Yanagida, K., Takami, M., Kodama, T. S., Mori, K., Nakayama, T., Ihara, Y., and Takeda, M. (2013)-Secretase modulators and presenilin 1 mutants act differently on presenilin/-secretase function to cleave A-42 and A-43. Cell Reports 3, 42-51
38. Lewis, P. A., Piper, S., Baker, M., Onstead, L., Murphy, M. P., Hardy, J., Wang, R., McGowan, E., and Golde, T. E. (2001) Expression of BRI-Amyloid-peptide fusion proteins. A novel method for specific high-level expression of amyloid-peptides. Biochim. Biophys. Acta 1537, 58-62
39. McGowan, E., Pickford, F., Kim, J., Onstead, L., Eriksen, J., Yu, C., Skipper, L., Murphy, M. P., Beard, J., Das, P., Jansen, K., Delucia, M., Lin, W. L., Dolios, G., Wang, R., Eckman, C. B., Dickson, D. W., Hutton, M., Hardy, J., Golde, T. (2005) A-42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47, 191-199
40. Kim, J., Onstead, L., Randle, S., Price, R., Smithson, L., Zwizinski, C., Dickson, D. W., Golde, T., and McGowan, E. (2007) A-40 inhibits amyloid deposition in vivo. J. Neurosci. 27, 627-633
41. Raymond, C., Tom, R., Perret, S., Moussouami, P., L'Abbé, D., St-Laurent, G., and Durocher, Y. (2011) A simplified polyethylenimine-mediated transfection process for large-scale and high-throughput applications. Methods 55, 44-51
42. Murphy, M. P., Hickman, L. J., Eckman, C. B., Uljon, S. N., Wang, R., and Golde, T. E. (1999)-Secretase, evidence for multiple proteolytic activities and influence of membrane positioning of substrate on generation of amyloid-peptides of varying length. J. Biol. Chem. 274, 11914-11923
43. Moore, B. D., Chakrabarty, P., Levites, Y., Kukar, T. L., Baine, A. M., Moroni, T., Ladd, T. B., Das, P., Dickson, D. W., and Golde, T. E. (2012) Overlapping profiles of A-peptides in the Alzheimer's disease and pathological aging brains. Alzheimers Res. Ther. 4, 18
44. Jung, J. I., Ladd, T. B., Kukar, T., Price, A. R., Moore, B. D., Koo, E. H., Golde, T. E., and Felsenstein, K. M. (2013) Steroids as-secretase modulators. FASEB J. 27, 3775-3785
45. Levites, Y., Das, P., Price, R. W., Rochette, M. J., Kostura, L. A., McGowan, E. M., Murphy, M. P., and Golde, T. E. (2006) Anti-A-42-And anti-A-40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model. J. Clin. Invest. 116, 193-201
46. Kimberly, W. T., Esler, W. P., Ye, W., Ostaszewski, B. L., Gao, J., Diehl, T., Selkoe, D. J., and Wolfe, M. S. (2003) Notch and the amyloid precursor protein are cleaved by similar-secretase(s). Biochemistry 42, 137-144
47. Fraering, P. C., LaVoie, M. J., Ye, W., Ostaszewski, B. L., Kimberly, W. T., Selkoe, D. J., and Wolfe, M. S. (2004) Detergent-dependent dissociation of active-secretase reveals an interaction between Pen-2 and PS1-NTF and offers a model for subunit organization within the complex. Biochemistry 43, 323-333
48. McGowan, E., Pickford, F., Kim, J., Onstead, L., Eriksen, J., Yu, C., Skipper, L., Murphy, M. P., Beard, J., Das, P., Jansen, K., Delucia, M., Lin, W. L., Dolios, G., Wang, R., Eckman, C. B., Dickson, D. W., Hutton, M., Hardy, J., and Golde, T. (2005) A-42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47, 191-199
49. Kukar, T. L., Ladd, T. B., Robertson, P., Pintchovski, S. A., Moore, B., Bann, M. A., Ren, Z., Jansen-West, K., Malphrus, K., Eggert, S., Maruyama, H., Cottrell, B. A., Das, P., Basi, G. S., Koo, E. H., and Golde, T. E. (2011) Lysine 624 of the amyloid precursor protein (APP) is a critical determinant of amyloid-peptide length. Support for a sequential model of-secretase intramembrane proteolysis and regulation by the amyloid-precursor protein (APP) juxtamembrane region. J. Biol. Chem. 286, 39804-39812
50. Tian, G., Sobotka-Briner, C. D., Zysk, J., Liu, X., Birr, C., Sylvester, M. A., Edwards, P. D., Scott, C. D., and Greenberg, B. D. (2002) Linear noncompetitive inhibition of solubilized human-secretase by pepstatin A methylester, L685458, sulfonamides, and benzodiazepines. J. Biol. Chem. 277, 31499-31505
51. Best, J. D., Smith, D. W., Reilly, M. A., O'Donnell, R., Lewis, H. D., Ellis, S., Wilkie, N., Rosahl, T. W., Laroque, P. A., Boussiquet-Leroux, C., Churcher, I., Atack, J. R., Harrison, T., and Shearman, M. S. (2007) The novel-secretase inhibitor N-[cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5- difluorophenyl) cyclohexyl]-1,1,1-trifl uoromethanesulfonamide (MRK-560) reduces amyloid plaque deposition without evidence of notch-related pathology in the Tg2576 mouse. J. Pharmacol. Exp. Ther. 320, 552-558
52. Fauq, A. H., Simpson, K., Maharvi, G. M., Golde, T., and Das, P. (2007) A multigram chemical synthesis of the-secretase inhibitor LY411575 and its diastereoisomers. Bioorg. Med. Chem. Lett. 17, 6392-6395
53. Holmes, O., Paturi, S., Ye, W., Wolfe, M. S., and Selkoe, D. J. (2012) Effects of membrane lipids on the activity and processivity of purified-secretase. Biochemistry 51, 3565-3575
54. Pinnix, I., Ghiso, J. A., Pappolla, M. A., and Sambamurti, K. (2013) Major carboxyl terminal fragments generated by-secretase processing of the Alzheimer amyloid precursor are 50 and 51 amino acids long. Am. J. Geriatr. Psychiatry 21, 474-483
55. Murphy, M. P., Uljon, S. N., Golde, T. E., and Wang, R. (2002) FAD-linked mutations in presenilin 1 alter the length of A-peptides derived from-APP transmembrane domain mutants. Biochim. Biophys. Acta 1586, 199-209
56. Mayer, S. C., Kreft, A. F., Harrison, B., Abou-Gharbia, M., Antane, M., Aschmies, S., Atchison, K., Chlenov, M., Cole, D. C., Comery, T., Diamantidis, G., Ellingboe, J., Fan, K., Galante, R., Gonzales, C., Ho, D. M., Hoke, M. E., Hu, Y., Huryn, D., Jain, U., Jin, M., Kremer, K., Kubrak, D., Lin, M., Lu, P., Magolda, R., Martone, R., Moore, W., Oganesian, A., Pangalos, M. N., Porte, A., Reinhart, P., Resnick, L., Riddell, D. R., Sonnenberg-Reines, J., Stock, J. R., Sun, S. C., Wagner, E., Wang, T., Woller, K., Xu, Z., Zaleska, M. M., Zeldis, J., Zhang, M., Zhou, H., and Jacobsen, J. S. (2008) Discovery of begacestat, a Notch-1-sparing-secretase inhibitor for the treatment of Alzheimer's disease. J. Med. Chem. 51, 7348-7351
57. Crump, C. J., Castro, S. V., Wang, F., Pozdnyakov, N., Ballard, T. E., Sisodia, S. S., Bales, K. R., Johnson, D. S., and Li, Y. M. (2012) BMS-708,163 targets presenilin and lacks notch-sparing activity. Biochemistry 51, 7209-7211
58. Golde, T. E., Koo, E. H., Felsenstein, K. M., Osborne, B. A., and Miele, L. (2013)-Secretase inhibitors and modulators. Biochim. Biophys. Acta 1828, 2898-2907
59. Weggen, S., Eriksen, J. L., Sagi, S. A., Pietrzik, C. U., Ozols, V., Fauq, A., Golde, T. E., and Koo, E. H. (2003) Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid-42 production by direct modulation of-secretase activity. J. Biol. Chem. 278, 31831-31837
60. Sagi, S. A., Lessard, C. B., Winden, K. D., Maruyama, H., Koo, J. C., Weggen, S., Kukar, T. L., Golde, T. E., and Koo, E. H. (2011) Substrate sequence influences-secretase modulator activity, role of the transmembrane domain of the amyloid precursor protein. J. Biol. Chem. 286, 39794-39803
61. Takami, M., and Funamoto, S. (2012)-Secretase-dependent proteolysis of transmembrane domain of amyloid precursor protein. Successive tri-And tetrapeptide release in amyloid-protein production. Int. J. Alzheimers Dis. 2012, 591392